CY1109564T1 - CONSOLIDATED SUPPLIED SUPPLIES OF Fatty Medicines - Google Patents

CONSOLIDATED SUPPLIED SUPPLIES OF Fatty Medicines

Info

Publication number
CY1109564T1
CY1109564T1 CY20091101284T CY091101284T CY1109564T1 CY 1109564 T1 CY1109564 T1 CY 1109564T1 CY 20091101284 T CY20091101284 T CY 20091101284T CY 091101284 T CY091101284 T CY 091101284T CY 1109564 T1 CY1109564 T1 CY 1109564T1
Authority
CY
Cyprus
Prior art keywords
consolidated
medicines
fatty
lipophilic
silica
Prior art date
Application number
CY20091101284T
Other languages
Greek (el)
Inventor
Adrian Funke
Torsten Wagner
Ralph Lipp
Original Assignee
Bayer Schering Pharma Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05718248A external-priority patent/EP1765290B1/en
Application filed by Bayer Schering Pharma Aktiengesellschaft filed Critical Bayer Schering Pharma Aktiengesellschaft
Publication of CY1109564T1 publication Critical patent/CY1109564T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε μία φαρμακολογική σύνθεση με βελτιωμένη διάλυση λιπόφιλων φαρμάκων σε ένα υδατικό μέσο. Έχει βρεθεί ότι φαρμακευτικές συνθέσεις που περιέχουν μία σκόνη λιπόφιλων ενώσεων, όπως ορμόνες και στεροειδή (π.χ. δροσπιρενόνη και βαλερική οιστραδιόλη), σε μοριακά διασπαρμένη μορφή μαζί με ένα φορέα που έχει ειδικό εμβαδόν επιφάνειας τουλάχιστον 250 m2/g, όπως διοξείδιο σίλικα, π.χ. διοξείδιο σίλικα που πωλείται με το όνομα Aeroperl®, έχουν βελτιωμένες ιδιότητες διάλυσης του λιπόφιλου φαρμάκου.The present invention relates to a pharmacological composition with improved dissolution of lipophilic drugs in an aqueous medium. It has been found that pharmaceutical compositions containing a powder of lipophilic compounds, such as hormones and steroids (e.g., drospirenone and estradiol valerate), in a molecularly dispersed form together with a carrier having a specific surface area of at least 250 m2 / g, such as silica, B.C. Silica dioxide sold under the name Aeroperl®, have improved dissolving properties of the lipophilic drug.

CY20091101284T 2004-03-10 2009-12-09 CONSOLIDATED SUPPLIED SUPPLIES OF Fatty Medicines CY1109564T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55133004P 2004-03-10 2004-03-10
EP04075714 2004-03-10
EP05718248A EP1765290B1 (en) 2004-03-10 2005-03-10 Stabilised supersaturated solid solutions of steroidal drugs

Publications (1)

Publication Number Publication Date
CY1109564T1 true CY1109564T1 (en) 2014-08-13

Family

ID=51535286

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091101284T CY1109564T1 (en) 2004-03-10 2009-12-09 CONSOLIDATED SUPPLIED SUPPLIES OF Fatty Medicines

Country Status (1)

Country Link
CY (1) CY1109564T1 (en)

Similar Documents

Publication Publication Date Title
NO20064473L (en) Stabilized supersaturated solid solutions of steroidal drugs
EA200601570A1 (en) COMPOSITIONS CONTAINING A MOLECULARLY DISPERSED DROSPYRENON
BR0307344A (en) Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase forming materials
Formariz et al. Structure and viscoelastic behavior of pharmaceutical biocompatible anionic microemulsions containing the antitumoral drug compound doxorubicin
TR200001810A2 (en) Immediate Melting Oral Dosage Formulation.
ATE413162T1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE SAFE ADMINISTRATION OF DRUGS USED IN THE TREATMENT OF DRUG DEPENDENCE
UY27642A1 (en) IMMEDIATE RELEASE DOSAGE FORMS CONTAINING SOLID DRUG DISPERSIONS
BRPI0418330A (en) solid compositions of low solubility drugs and poloxamers
DE60136648D1 (en) PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE WITH INCREASED BIOAVAILABILITY AND METHOD FOR THEIR USE
CO5690532A2 (en) PHARMACEUTICAL DOSAGE FORMS OF EXTENDED LIBERATION
UY27929A1 (en) PHARMACEUTICAL COMPOSITIONS OF SEMIORDENED AND POLYMER DRUGS
ATE382356T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING ESTETROL DERIVATIVES AND USE IN CANCER TREATMENT
GT200500122A (en) STEROID PROPHARMS WITH ANDROGENIC ACTION
TN2009000119A1 (en) Combination drug
CY1109564T1 (en) CONSOLIDATED SUPPLIED SUPPLIES OF Fatty Medicines
ES2173848T3 (en) NANOEMULSION BASED ON ALCOXYLATED ALQUENISUCCINATES OR ALKENYL SUCCINATES OF ALCOXYLED GLUCOSE AND ITS USES IN THE COSMETIC, DERMATOLOGICAL, OPHTHALMOLOGICAL AND / OR PHARMACEUTICAL ENVIRONMENTS.
DE60121293D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING STEROIDICAL STRUCTURES AND ITS USES
FR2865733B1 (en) THIAZOLYLIMIDAZOLE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND MEDICINE APPLICATIONS THEREOF
Sayani et al. Drug interactions of newer oral anticoagulants dabigatran, rivaroxaban, and apixaban with routinely used nonanticoagulant/antiplatelet drugs
UA87838C2 (en) Stabilised supersaturated solids of lipophilic drugs
IL182412A (en) Complex that includes mequitazine, a cyclodextrin and l-arginine as an interaction agent, a method of preparing the complex, a pharmaceutical composition that includes the complex and the complex for use as a drug
TH75689A (en) Super-saturated lipophilic stabilized solids
AR048002A1 (en) MOLECULAR DISPERSIONS OF DROSPIRENONA
SE0102933D0 (en) Lipid carrier
CY1115072T1 (en) LIQUID COMPOSITIONS SPRAY FOR SUPPLY OF CANNIVOIDES THROUGH PARTY